At closing bell, the benchmark S&P/ASX200 was up 62.89 points, or 0.86%, to 7,355.05. The broader All Ordinaries index added 64.47 points, or 0.86%, to 7,666.69.
The top performing stocks in this index were NANOSONICS and ZIP CO., up 7.46% and 5.08% respectively. The bottom performing stocks in this index were PILBARA MINERALS and LIONTOWN RESOURCES, down 9.06% and 4.19% respectively.
Total 10 of 11 sectors ended higher along with incline in the S&P/ASX 200 Index. Health Care was the best performing sector, gaining +3.9%, while energy was the worst performing sector, falling 0.37%.
Shares of healthcare sector out-performed the market, with medical diagnostics company Sonic Healthcare closing at a new high of A$45.47. ACL jumped 12.2% after upgrading guidance due to higher COVID testing levels. Cochlear gained 3.9%, Nanosonics gained 7.5%, and Ramsay Health closed 3.1% higher at $70.31.
ECONOMIC NEWS: Omicron Poses Uncertainty But Not Expected To Derail Economic Recovery, Says RBA- The RBA Board decided to maintain the cash rate target at 10 basis points and the interest rate on Exchange Settlement balances at zero% and to continue to purchase government securities at the rate of $4 billion a week until at least mid February 2022. The Board remained committed to maintaining highly supportive monetary conditions to achieve its objectives of a return to full employment and inflation consistent with the target. As previously determined, the Board will not increase the cash rate until actual inflation is sustainably within the 2 to 3% target range. This will require the labour market to be tight enough to generate wages growth that is materially higher than it is currently. This is likely to take some time and the Board is prepared to be patient. The Australian economy was rapidly recovering after the interruption to growth caused by the outbreak of the Delta variant of COVID-19, the Reserve Bank of Australia's (RBA) December meeting minutes showed. "High rates of vaccination and substantial policy support continued to underpin the recovery," it noted, adding that the emergence of the Omicron variant was a new source of uncertainty but it was not expected to derail the recovery.
CURRENCY NEWS: The Australian dollar was at $0.7117, still struggling to recover after last week's decline from above $0.72.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
